Fig. 1From: Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathya Vitreous LCN2 levels in eyes with nondiabetic control group and eyes with PDR. b Vitreous vascular endothelial growth factor (VEGF) level in eyes nondiabetic control group and eyes with PDR. PDR = proliferative diabetic retinopathy. * P < .0001Back to article page